Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...

As a consequence of Pfizer’s innovation, the price of citric acid tumbled over ... Pfizer seemed unable to allay the concerns of prime minister David Cameron and business secretary Vince Cable.

The analyst's commentary reflects careful consideration of Haleon's latest guidance and market conditions, particularly the ...

Jefferies reiterated its Buy rating on Haleon PLC (HLN:LN) (NYSE: HLN), maintaining a price target of GBP4.50. Currently ...

Business travel is in full swing in 2005 and suppliers are making structural changes with pricing that move them toward the ...

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

Thursday’s total option volume of 49.3 million contracts resulted in net open interest growth of 6.65 million calls and 5.92 million puts.

PFE) will increase its dividend from last year's comparable payment on the 7th of March to $0.43. This will take the annual payment to 6.5% of the stock price, which is above what most companies ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE ... The core consumer price index (CPI), which excludes volatile food and energy prices, increased by 0.2%, down from ...

With morale at a low point, biotech and pharma CEOs are cautiously optimistic about the incoming Trump administration.

List of drugs account for $41 billion in annual Medicare spending, the Biden administration said.